Basic Information
| LncRNA/CircRNA Name | LINC01210 |
| Synonyms | NA |
| Region | GRCh38_3:137771949-137780878 |
| Ensemble | ENSG00000239513 |
| Refseq | NR_109987 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, RIP |
| Sample | OC tissues,cell lines( A2780 , HO8910) |
| Expression Pattern | up-regulated |
| Function Description | LINC01210 was upregulated in OC tissues and KLF4 was downregulated. LINC01210 level was higher in OC patients with metastases or advanced stage. |
| Pubmed ID | 31514068 |
| Year | 2019 |
| Title | LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4. |
External Links
| Links for LINC01210 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |